The mosaic of autoimmunity

Autoimmunity Reviews

Volumn 7, Issue 3, 2008, Pages 161-163

  Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; PHOSPHOLIPID ANTIBODY;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; EDITORIAL; GENOMICS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; KIDNEY DISEASE; MEDICAL SPECIALIST; PROTEOMICS; ANIMAL; AUTOIMMUNITY; CONFERENCE PAPER; HISTORY; IMMUNOLOGY;

AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LABYRINTH DISEASES; ALLERGY AND IMMUNOLOGY; ANIMALS; AUTOIMMUNE DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY;

EID: 37649017574     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.11.021     Document Type: Editorial

References (40)

1. Ablin J.N., Shoenfeld Y., and Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 27 (2006) 52-145
2. Akbarali Y., Matousek-Ronck J., Hunt L., Staudt L., Reichlin M., Guthridge J.M., et al. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun 27 (2006) 80-272
3. Allina J., Hu B., Sullivan D.M., Fiel M.I., Thung S.N., Bronk S.F., et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27 (2006) 41-232
4. Alper C.A., Husain Z., Larsen C.E., Dubey D.P., Stein R., Day C., et al. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 27 (2006) 89-95
5. Awdeh Z.L., Yunis E.J., Audeh M.J., Fici D., Pugliese A., Larsen C.E., et al. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27 (2006) 81-174
6. Barak Y. The immune system and happiness. Autoimmun Rev 5 (2006) 523-527
7. Barral A.M., Thomas H.E., Ling E.M., Darwiche R., Rodrigo E., Christen U., et al. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J Autoimmun 27 (2006) 166-173
8. Borchers A.T., Selmi C., Cheema G., Keen C.L., Shoenfeld Y., and Gershwin M.E. Juvenile idiopathic arthritis. Autoimmun Rev 5 (2006) 279-298
9. Cervera R., Espinosa G., Bucciarelli S., Gomez-Puerta J.A., and Font J. Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun Rev 6 (2006) 81-84
10. Chang X., Zheng P., and Liu Y. FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun Rev 5 (2006) 399-402
11. Duhalde-Vega M., Loureiro M.E., Mathieu P.A., and Retegui L.A. The peptide specificities of the autoantibodies elicited by mouse hepatitis virus A59. J Autoimmun 27 (2006) 203-209
12. Galeazzi M., Bellisai F., Manganelli S., Morozzi G., and Sebastiani G.D. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. Autoimmun Rev 5 (2006) 493-498
13. Gergely Jr. P., Perl A., and Poor G. Possible pathogenic nature of the recently discovered TT virus: does it play a role in autoimmune rheumatic diseases?. Autoimmun Rev 6 (2006) 5-9
14. Gomez-Puerta J.A., Cervera R., Espinosa G., Bucciarelli S., and Font J. Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome. Autoimmun Rev 6 (2006) 85-88
15. Iverson G.M., von Muhlen C.A., Staub H.L., Lassen A.J., Binder W., and Norman G.L. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI. J Autoimmun 27 (2006) 266-271
16. Kiss E., Soltesz P., Der H., Kocsis Z., Tarr T., Bhattoa H., et al. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmun 27 (2006) 211-217
17. Kong J.S., Teuber S.S., and Gershwin M.E. Potential adverse events with biologic response modifiers. Autoimmun Rev 5 (2006) 471-485
18. Konova E., Atanasova M., Stoykov S., Velkova A., and Shoenfeld Y. Idiotypic and anti-idiotypic elastin autoantibodies: implications for IVIg and pregnancy loss. J Autoimmun 28 (2007) 46-54
19. Koutouzov S., Mathian A., and Dalloul A. Type-I interferons and systemic lupus erythematosus. Autoimmun Rev 5 (2006) 554-562
20. Lo J., and Clare-Salzler M.J. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Autoimmun Rev 5 (2006) 419-423
21. Mandler R.N. Neuromyelitis optica - Devic's syndrome, update. Autoimmun Rev 5 (2006) 537-543
22. Martinez-Gamboa L., Brezinschek H.P., Burmester G.R., and Dorner T. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmun Rev 5 (2006) 437-442
23. Mix E., Ibrahim S.M., Pahnke J., Glass A., Mazon-Pelaez I., Lemcke S., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. J Autoimmun 27 (2006) 251-265
24. Moritoki Y., Lian Z.X., Ohsugi Y., Ueno Y., and Gershwin M.E. B cells and autoimmune liver diseases. Autoimmun Rev 5 (2006) 449-457
25. Nilsson B.O., Skogh T., Ernerudh J., Johansson B., Lofgren S., Wikby A., et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun 27 (2006) 281-288
26. Nowling T.K., and Gilkeson G.S. Regulation of Fli1 gene expression and lupus. Autoimmun Rev 5 (2006) 377-382
27. Okada T., Inaba M., Naiki M., Lian Z.X., Gershwin M.E., and Ikehara S. Comparative immunobiology of thymic DC mRNA in autoimmune-prone mice. J Autoimmun 28 (2007) 41-45
28. Periolo N., and Chernavsky A.C. Coeliac disease. Autoimmun Rev 5 (2006) 202-208
29. Reveille J.D. The genetic basis of autoantibody production. Autoimmun Rev 5 (2006) 389-398
30. Rieger R., Leung P.S., Jeddeloh M.R., Kurth M.J., Nantz M.H., Lam K.S., et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 27 (2006) 7-16
31. Rosloniec E.F., Brandstetter T., Leyer S., Schwaiger F.W., and Nagy Z.A. Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models. J Autoimmun 27 (2006) 182-195
32. Rovensky J. Rheumatic diseases and Klinefelter's syndrome. Autoimmun Rev 6 (2006) 33-36
33. Schwartz N., Su L., Burkly L.C., Mackay M., Aranow C., Kollaros M., et al. Urinary TWEAK and the activity of lupus nephritis. J Autoimmun 27 (2006) 242-250
34. Sharma R., Zheng L., Guo X., Fu S.M., Ju S.T., and Jarjour W.N. Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J Autoimmun 27 (2006) 289-296
35. Smith C.E., and Miller S.D. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. J Autoimmun 27 (2006) 218-231
36. Sodin-Semrl S., Zigon P., Cucnik S., Kveder T., Blinc A., Tomsic M., et al. Serum amyloid A in autoimmune thrombosis. Autoimmun Rev 6 (2006) 21-27
37. Toubi E., Gordon S., Kessel A., Rosner I., Rozenbaum M., Shoenfeld Y., et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 27 (2006) 134-139
38. Vaglio A., Greco P., Corradi D., Palmisano A., Martorana D., Ronda N., et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5 (2006) 458-464
39. Wandstrat A.E., Carr-Johnson F., Branch V., Gray H., Fairhurst A.M., Reimold A., et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 27 (2006) 153-160
40. Yang L.J. Liver stem cell-derived beta-cell surrogates for treatment of type 1 diabetes. Autoimmun Rev 5 (2006) 409-413